ASSOCIATION OF ANXIETY AND DEPRESSIVE SYMPTOMS WITH HYPOTHYROIDISM
Main Article Content
Keywords
Sociodemographic profile, depression, anxiety, gender differences in symptoms, HDRS, HAM-A scores
Abstract
Introduction: Hypothyroidism, characterized by insufficient production of thyroid hormones by the thyroid gland, affects millions of individuals worldwide, with prevalence varying across different populations and age groups. Thyroid hormones play a crucial role in regulating metabolism, energy expenditure, and the functioning of various organs, including the brain
Objective: To examine the relationship between anxiety and depressive symptoms with hypothyroidism, exposing its clinical implications and therapeutic strategies.
Methodology: This study is a cross-sectional retrospective analysis conducted at Lady Reading Hospital in Peshawar. A total of 103 participants were retrospectively selected from medical records at Lady Reading Hospital between January 2023 and January 2024. Anxiety and depression were assessed using validated tools such as the Hospital Anxiety and Depression Scale (HADS) or the Beck Depression Inventory (BDI). These tools were administered during routine clinical visits or through self-report questionnaires. Anxiety and depression were assessed using standardized scales administered during clinical evaluations. The Hamilton Depression Rating Scale (HDRS) and the Hamilton Anxiety Rating Scale (HARS) are commonly utilized clinician-administered tools for evaluating the severity of depressive and anxiety symptoms, respectively.
Results: The study's sociodemographic profile revealed a majority of females (71%), with most participants aged 25-34 (52%), married (72%), and educated beyond matric level (79%). No statistically significant differences were found. Regarding depression, 60.1% exhibited symptoms, with no significant gender disparity. Similarly, 65% showed anxiety, with no significant gender difference. However, specific symptoms showed gender variations: males showed more depressed mood and anxiety with genital symptoms, while females exhibited more gastrointestinal symptoms and hypochondriasis. Moreover, HAM-A scores indicated significant differences in symptoms like anxious mood, tension, fears, and somatic symptoms between genders. Notably, a significant association was found between HDRS and HAM-A scores (P = 0.045).
Conclusion: Since thyroid hormones (THs) are essential for controlling mood, behaviour, and thought processes, there is reason for great concern over the relationship between thyroid function and mental illnesses. Thyroid dysfunctions have been linked to learning and memory deficits, as well as psychiatric comorbidities such as anxiety and depressive disorders. In order to optimise their therapy, patients presenting with these symptoms must undergo treatment and monitoring from both an endocrinologist and a psychiatrist. Early detection of an endocrine disorder can lower mental morbidity and eventually enhance general health results.
References
2. Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007;3(3):249-59.
3. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-86.
4. Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res. 2012;2012:590648.
5. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20(10):1101-14.
6. Duntas LH, Maillis A. Hypothyroidism and depression: salient aspects of pathogenesis and management. Minerva Endocrinol. 2013;38(4):365-77.
7. Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry. 1988;145(3):325-30.
8. Tiller JWG. Depression and thyroid disease. J Psychosom Res. 1996;40(3):203-13.
9. Redmond GP. Hypothyroidism and women’s health. Int J Fertil Womens Med 2002;47:123 7.
10. Chaudhary R, Chabra S, Singla M, Mishra BP, Sharma A. Psychiatric morbidity among hypothyroid patients – A hospital based study. Delhi Psychiatry J 2014;17:35 8.
11. Pies RW. Women, mood, and the thyroid. Women Psychiatry Health 1995;4:4 10.
12. SaltevoJ, KautiainenH, Mäntyselkä P, JulaA, Keinänen KiukaanniemiS, Korpi Hyövälti E, et al. The relationship between thyroid function and depressive symptoms the FIN D2D population based study. Clin Med Insights Endocrinol Diabetes 2015;8:29 33.
13. BlumMR, WijsmanLW, VirginiVS, BauerDC, den ElzenWP, JukemaJW, et al. Subclinical thyroid dysfunction and depressive symptoms among elderly: A prospective cohort study. Neuroendocrinology 2015;DOI: 10.1159/000437387. [Epub ahead of print].
14. Kvetny J, Ellervik C, Bech P. Is suppressed thyroid stimulating hormone (TSH) associated with subclinical depression in the Danish General Suburban Population Study? Nord J Psychiatry 2015;69:282 6.
15. Haug TT, Mykletun A, Dahl AA. The association between anxiety, depression, and somatic symptoms in a large population: The Hunt II study. Psychosom Med 2004;66:845 51.
16. Hall RC. Psychiatric effects of thyroid hormone disturbance. Psychosomatics 1983;24:7 22.
17. Ittermann T, Völzke H, Baumeister SE, Appel K, Grabe HJ. Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol 2015;50:1417 25.
18. Cosci F, Fava GA, Sonino N. Mood and anxiety disorders as early manifestations of medical illness: A systematic review. Psychother Psychosom 2015;84:22 9.
19. Benseñor IM, Nunes MA, Sander Diniz MF, Santos IS, Brunoni AR, Lotufo PA. Subclinical thyroid dysfunction and psychiatric disorders: Cross sectional results from the Brazilian Study of Adult Health (ELSA Brasil). Clin Endocrinol (Oxf) 2015;84:250-6.
20. Krysiak R, Drosdzol Cop A, Skrzypulec Plinta V, Okopien B. Sexual function and depressive symptoms in young women with thyroid autoimmunity and subclinical hypothyroidism. Clin Endocrinol (Oxf) 2015;DOI: 10.1111/cen.12956.